Table 3.
Prevalence of inappropriate drug prescription (Independent of disease or condition)
| Drugs | Severity* | Number of patients as a percentage of total (N = 1669) |
| Pentazocine | High | 0.2 |
| Muscle relaxants and antispasmodics | High | 0.9 |
| Amitriptyline | High | 0.0 |
| Long-acting benzodiazepines | High | 1.9 |
| Disopyramide | High | 0.2 |
| Digoxin >0.125 mg/d | Low | 0.0 |
| Short-acting dipyridamole | Low | 0.0 |
| Gastrointestinal antispasmodic drugs | High | 0.1 |
| Anticholinergics and antihistamines | High | 1.4 |
| Ferrous sulfate>325 mg/d | Low | 0.2 |
| Ticlopidine | High | 6.3 |
| Doxazosin | Low | 1.5 |
| Thioridazine | High | 0.1 |
| Short-acting nifedipine | High | 2.0 |
| Cimetidine | Low | 1.5 |
| Indomethacin | High | 0.1 |
| Desiccated thyroid | High | 0.1 |
| Methyldopa | High | 0.1 |
| Use of any inappropriate drugs | 21.1 |
* Severity: Defined conceptually as a combination of both the likelihood that an adverse outcome would occur and the clinical significance of that outcome should it occur [7].